Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva’s Licensing Agreement Requirements
REHOVOT, ISRAEL – February 29, 2024 – Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and...
